News

CD Bioparticles Introduces Comprehensive RNA Synthesis Services to Accelerate LNP-mRNA Vaccine and Therapeutic Development

  • by

CD Bioparticles launches specialized RNA Synthesis services for researchers to develop next-generation mRNA vaccines, gene therapies, and RNA-based therapeutics. New York, NY, United States, February 10, 2026 — CD Bioparticles, a leading manufacturer and supplier… Read More »CD Bioparticles Introduces Comprehensive RNA Synthesis Services to Accelerate LNP-mRNA Vaccine and Therapeutic Development